KIAA1755 is a protein that, similar to the LOC nomenclature, has been identified through systematic sequencing of large genomic regions but has not been thoroughly characterized in terms of function. The "KIAA" prefix denotes that the protein was first identified in a large-scale cDNA sequencing project conducted by the Kazusa DNA Research Institute in Japan. The number "1755" serves as a unique identifier for this specific protein within the KIAA project database.The KIAA1755 protein is encoded by a gene that is predicted based on the sequence of cDNA clones. The gene's mRNA expression patterns, as well as the predicted amino acid sequence of the protein, may provide preliminary clues about its function. Often, KIAA proteins are of interest because they may represent novel proteins with potential roles in cellular biology that have not been previously described.
The study of KIAA1755 would include examining its sequence for recognizable motifs, domains, or signatures that could suggest a biological function. For example, a DNA binding domain might imply a role in transcriptional regulation, while a kinase domain might suggest involvement in signal transduction pathways.Bioinformatics tools can be used to predict subcellular localization, post-translational modifications, and potential interaction partners for KIAA1755. Experimental approaches, such as gene knockdown or overexpression studies, protein interaction assays, and localization studies, are essential to confirm these predictions and determine the physiological role of KIAA1755.
VOIR ÉGALEMENT...
Items 1 to 10 of 11 total
Afficher:
| Nom du produit | CAS # | Ref. Catalogue | Quantité | Prix HT | CITATIONS | Classement |
|---|---|---|---|---|---|---|
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
inhibiteur de la pompe SERCA, entraîne une augmentation des niveaux de calcium cytosolique, affectant potentiellement EFCAB14/KIAA1755 par le biais de voies de signalisation liées au calcium. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
Ionophore qui augmente les niveaux de calcium intracellulaire, affectant potentiellement l'activité de EFCAB14/KIAA1755 en modifiant les voies de signalisation dépendantes du calcium. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $27.00 $52.00 | 37 | |
Modifie la libération de calcium intracellulaire, influençant potentiellement l'activité de EFCAB14/KIAA1755 par le biais de la signalisation calcique. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Augmente les niveaux de calcium intracellulaire, influençant potentiellement l'activité de EFCAB14/KIAA1755 par le biais d'une signalisation dépendante du calcium. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $449.00 | 61 | |
Chélateur du calcium intracellulaire, pourrait indirectement affecter l'activité de EFCAB14/KIAA1755 en modulant la signalisation calcique. | ||||||
EGTA | 67-42-5 | sc-3593 sc-3593A sc-3593B sc-3593C sc-3593D | 1 g 10 g 100 g 250 g 1 kg | $20.00 $62.00 $116.00 $246.00 $799.00 | 23 | |
Le chélateur de calcium, utilisé pour étudier le rôle du calcium extracellulaire, pourrait influencer indirectement EFCAB14/KIAA1755. | ||||||
Nimodipine | 66085-59-4 | sc-201464 sc-201464A | 100 mg 1 g | $60.00 $301.00 | 2 | |
Bloqueur de canaux calciques, principalement de type L, influençant potentiellement l'activité de EFCAB14/KIAA1755 en modifiant l'influx de calcium. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
Un autre inhibiteur des canaux calciques, affecte l'influx de calcium, influençant potentiellement l'activité de EFCAB14/KIAA1755. | ||||||
Ryanodine | 15662-33-6 | sc-201523 sc-201523A | 1 mg 5 mg | $219.00 $765.00 | 19 | |
Modifie la libération de calcium du réticulum sarcoplasmique/endoplasmique, pourrait affecter l'activité de EFCAB14/KIAA1755. | ||||||
SK&F 96365 | 130495-35-1 | sc-201475 sc-201475B sc-201475A sc-201475C | 5 mg 10 mg 25 mg 50 mg | $101.00 $155.00 $389.00 $643.00 | 2 | |
Inhibiteur de l'entrée du calcium dans les réserves, influençant potentiellement l'activité de EFCAB14/KIAA1755. | ||||||